Sold
Available
IBL-26-2743

Composition for 1,2-Propylene Glycol Production Using Methylotrophic Bacteria and Production Method Thereof

Listed on
2026-10-27
Technology for Methanol-Based 1,2-Propylene Glycol Production Using Methylotrophic Bacterial Metabolic Engineering

This technology involves a strain and production composition that establishes a 1,2-propylene glycol biosynthetic pathway by transforming methylotrophic bacteria with a recombinant vector containing the methylglyoxal synthase (mgsA), glycerol dehydrogenase (gldA), and methylglyoxal reductase (yqhD) genes. The target substance is obtained by culturing the bacteria in NMS medium using methanol as a carbon source.

Most 1,2-propylene glycol is currently produced via petrochemical processes, which generate harmful intermediates and byproducts during propylene oxide conversion and hydrolysis. Microbial fermentation using E. coli or yeast relies on sugars like glucose or glycerol, leading to issues with rising raw material costs and competition with food resources.

This technology introduces foreign genes, including Bacillus subtilis-derived methylglyoxal synthase, into Methylobacterium extorquens strains that do not naturally produce 1,2-propylene glycol, enabling the production of the target substance from inexpensive, highly soluble methanol. Since it does not use sugar as a substrate, it reduces risks of food competition and fermentation contamination. Applicable to the production of antifreeze, polyester resins, cosmetics, and detergent ingredients, it secures an eco-friendly process for converting methanol derived from shale or biogas into high-value chemical raw materials.

‍

‍

Key Features:
  • Methylotrophic bacteria transformed with a recombinant vector containing nucleic acid sequences encoding methylglyoxal synthase, glycerol dehydrogenase, and methylglyoxal reductase
  • Composition for 1,2-propylene glycol production comprising NMS medium and transformed methylotrophic bacteria where the methylglyoxal synthase is derived from Bacillus subtilis
  • A transformation step of transforming methylotrophic bacteria with a recombinant vector and a culture step of culturing the transformed strain in NMS medium
  • Methylotrophic bacterial host selected from Methylobacterium extorquens, suomiense, platani, adhaesivum, soli, and chloromethanicum

‍

This invention was developed with support from the Ministry of Science and ICT's C1 Gas Conversion Technology common research project.

‍

Sogang University
Jin-Won Lee | Jeong-Geol Na | Hyun-Soo Kim | Gyo-Yeon Seo | Sook-Hyung Cho | Seon-Young Ha
Document
Date of application:
2018-11-05
|
Patent registration number:
10-2173766
Industry
bio
chemicals
Technology
Bio/Pharmaceutical
Country
Korea
Family Patent

N/A

Price
Price negotiable
Subscribe to our newsletter to receive the latest patent information faster than anyone else.
← Back to list